Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent
Crossref DOI link: https://doi.org/10.1186/s13098-015-0087-3
Published Online: 2015-10-19
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tang, Yun-Zhao
Wang, Gang
Jiang, Zhen-Huan
Yan, Tian-Tian
Chen, Yi-Jun
Yang, Min
Meng, Ling-Ling
Zhu, Yan-Juan
Li, Chen-Guang
Li, Zhu
Yu, Ping
Ni, Chang-Lin